FdaApplication
ANDA 061450
Identifiers
- fda_app_no: ANDA061450
Properties
| Property | Value |
|---|---|
| applicant_name | APOTHECON INC DIV BRISTOL MYERS SQUIBB |
| application_type | ANDA |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OXACILLIN SODIUM | OXACILLIN SODIUM | EQ 500MG BASE | CAPSULE;ORAL |
| OXACILLIN SODIUM | OXACILLIN SODIUM | EQ 250MG BASE | CAPSULE;ORAL |
2 products